Evidence map›Paper›PMID 41970590›Full record

ArticleBiomedical optics express2026

Multimodal optical system for quantitative discrimination of bilirubin species.

Jan Zwicky, Daniel Fehr, Ina Albert, Steffi Lehmann, Lilian Witthauer, Mathias Bonmarin

Abstract read
In one paragraph

Article in Biomedical optics express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jan ZwickySchool of Engineering, Zurich University of Applied Sciences (ZHAW), Technikumstrasse 71, Winterthur, 8401, Switzerland.ORCID https://orcid.org/0009-0006-5434-0758
Daniel FehrSchool of Engineering, Zurich University of Applied Sciences (ZHAW), Technikumstrasse 71, Winterthur, 8401, Switzerland.ORCID https://orcid.org/0000-0002-4863-8658
Ina AlbertSchool of Life Sciences and Facility Management, Zurich University of Applied Sciences (ZHAW), Grüentalstrasse 14, Wädenswill, 8820, Switzerland.ORCID https://orcid.org/0000-0001-7201-3642
Steffi LehmannSchool of Life Sciences and Facility Management, Zurich University of Applied Sciences (ZHAW), Grüentalstrasse 14, Wädenswill, 8820, Switzerland.ORCID https://orcid.org/0000-0002-0411-027X
Lilian WitthauerDepartment of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 3, Bern, 3010, Switzerland.ORCID https://orcid.org/0000-0001-9459-875X
Mathias BonmarinSchool of Engineering, Zurich University of Applied Sciences (ZHAW), Technikumstrasse 71, Winterthur, 8401, Switzerland.ORCID https://orcid.org/0000-0003-0227-9247

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bilirubin occurs in human serum in multiple molecular forms: free unconjugated, albumin-bound, and conjugated species, and distinguishing between them is clinically relevant for assessing liver function and bilirubin metabolism. However, current routine assays do not resolve these subtypes individually. Here, we present a compact, multimodal optical platform that combines absorbance spectroscopy, fluorescence intensity, fluorescence anisotropy, and photobleaching analysis to investigate the optical signatures of bilirubin species in solution. Using well-defined synthetic standards representing free, bound, and conjugated bilirubin, we characterize each modality's discriminative capability. Absorbance measurements enable total bilirubin determination, fluorescence provides high sensitivity to albumin-bound bilirubin, and anisotropy measurements, done with a plate reader, reveal different responses to each species through their differing rotational mobilities. Photobleaching kinetics further highlight species-dependent photostability under controlled irradiance conditions. Taken together, these complementary, label-free optical readouts enable improved resolution of bilirubin subtypes in synthetic samples and establish a foundation for future translational studies in biologically complex matrices.

Identifiers

PMID41970590
PMCPMC13064630

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.